Immune Cell Transfer – Definition and Therapy
Immune cell transfer is a medical procedure in which immune cells are taken from a donor or patient and infused into a recipient to treat cancer or immune disorders.
Wissenswertes über "Immune Cell Transfer"
Immune cell transfer is a medical procedure in which immune cells are taken from a donor or patient and infused into a recipient to treat cancer or immune disorders.
What is Immune Cell Transfer?
Immune cell transfer – also known as adoptive cell transfer (ACT) – is a therapeutic approach in which immune cells are collected from a patient or a healthy donor, processed or genetically engineered in a laboratory, and then infused back into the patient. The goal is to enhance or redirect the immune response to fight diseases such as cancer, chronic viral infections, or certain immune disorders. This method is a cornerstone of modern immunotherapy and represents one of the most active areas of personalized medicine research.
Types of Immune Cell Transfer
Autologous Cell Transfer
In autologous immune cell transfer, the patient's own immune cells are harvested, expanded, activated, or genetically modified in a laboratory before being reinfused. The most well-known example is CAR-T cell therapy, in which T lymphocytes are engineered to express a chimeric antigen receptor (CAR) that enables them to specifically recognize and destroy tumor cells.
Allogeneic Cell Transfer
In allogeneic immune cell transfer, immune cells are obtained from a healthy matched donor. This approach is commonly used in the context of stem cell transplantation and takes advantage of the graft-versus-leukemia (GvL) effect, where donor immune cells recognize and eliminate residual cancer cells in the recipient.
Mechanism of Action
Immune cell transfer exploits the natural ability of immune cells – particularly T cells, natural killer (NK) cells, and dendritic cells – to identify and eliminate pathogens or abnormal cells. By selecting, activating, or genetically modifying these cells outside the body, their therapeutic potency is significantly enhanced. Once reinfused, these cells seek out their target structures and mount a directed immune response against them.
Clinical Applications
- Oncology: Treatment of leukemias, lymphomas, and solid tumors (e.g., via CAR-T cell therapy)
- Infectious diseases: Management of chronic viral infections such as HIV or cytomegalovirus (CMV) reactivation after transplantation
- Autoimmune conditions: Experimental use to modulate dysregulated immune responses
- Stem cell transplantation: Donor T cell infusions to combat residual leukemia after allogeneic transplant
Benefits and Opportunities
Compared to conventional treatments such as chemotherapy or radiation, immune cell transfer offers the advantage of a highly targeted mechanism of action with potentially fewer off-target effects on healthy tissue. In certain cancers refractory to standard therapies, CAR-T cell-based approaches have achieved remarkable and durable remissions.
Risks and Side Effects
Despite promising results, immune cell transfer is associated with notable risks. These include:
- Cytokine release syndrome (CRS): A potentially life-threatening systemic inflammatory response triggered by massive immune activation
- Graft-versus-host disease (GvHD): In allogeneic transfers, donor cells may attack the recipient's healthy tissues
- Neurotoxicity: Neurological side effects observed particularly with CAR-T cell therapies
- Infection risk: Due to temporary immunosuppression used to prepare the patient before therapy
Current Developments and Outlook
Research in immune cell transfer is advancing rapidly. In addition to CAR-T cells, TCR-engineered T cells (with modified T cell receptors) and NK cell-based therapies are being intensively investigated. Researchers aim to make these therapies safer, more effective, and more widely accessible – including for patients with solid tumors, where current CAR-T approaches show limited efficacy. There is also growing interest in off-the-shelf cell products derived from donor material, which could be manufactured in advance and deployed quickly and cost-effectively.
References
- Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015;348(6230):62-68.
- June CH, Sadelain M. Chimeric Antigen Receptor Therapy. New England Journal of Medicine. 2018;379(1):64-73.
- National Cancer Institute (NCI). CAR T Cells: Engineering Immune Cells to Treat Cancer. Available at: https://www.cancer.gov. Accessed 2024.
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryExtrauterine
Fatty Acid Esters
Mineral Synergy
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Immune Cell Transfer + Immune-Cell Transfer + Immunocyte Transfer